UPDATED August 1, 2022
The COVID-19 vaccine situation is continually evolving. Information is changing daily, if not hourly. Please note that the situation may have changed since the last webpage update.
Los Angeles County Vaccination Sites to Start Administering Novavax Vaccine Beginning Wednesday, August 3
Unlike the Pfizer-BioNTech and Moderna vaccines, the Novavax vaccine was developed without the use of mRNA technology. The vaccine was found to be 90% effective against mild, moderate and severe disease in the company’s Phase 3 clinical trial involving 30,000 participants ages 18 and older. Residents 18 years and older can get the Novavax vaccine, which is a two-dose primary series, with the second dose administered three weeks after the first. Boosters are currently not recommended and the Novavax vaccine is not yet authorized for children 17 and younger. Residents can walk into any Los Angeles County Department of Public Health vaccination location to receive the vaccine and contact their provider to see if their provider is offering Novavax. August 1, 2022
CDC Recommends Novavax’s COVID-19 Vaccine for Adults
Novavax’s COVID-19 vaccine can be used as another primary series option for adults ages 18 years and older. Novavax’s COVID-19 vaccine, which will be available in the coming weeks, consists of 2 doses in the primary series, given 3–8 weeks apart. People who are moderately or severely immunocompromised should also receive 2 doses, given 3 weeks apart (a 3rd primary dose is not currently authorized). Novavax COVID-19 vaccine is not authorized for use as a booster dose.
The Novavax vaccine was developed using protein-based technology instead of mRNA technology. Protein subunit vaccines package harmless proteins of the COVID-19 virus alongside another ingredient called an adjuvant that helps the immune system respond to the virus in the future. Vaccines using protein subunits have been used for more than 30 years in the United States, beginning with the first licensed hepatitis B vaccine. Other protein subunit vaccines used in the United States today include those to protect against influenza and whooping cough (acellular pertussis).
For more information on the Novavax vaccine, click here.
New CDC COVID-19 Vaccine Recommendations for Children
The Centers for Disease Control and Prevention (CDC) now recommends COVID-19 vaccination with Pfizer and Moderna vaccines for children 6 months and older.
Moderna and Pfizer COVID-19 vaccines for children 6 months-5 years of age
The CDC recommends either:
• Moderna COVID-19 vaccine for children ages 6 months through 5 years of age: Administered as 2 doses, 25 mcg per dose, 4 to 8 weeks apart.
• Pfizer COVID-19 vaccine for children ages 6 months through 4 years of age: Administered as 3 doses, 3 mcg per dose, with the first two doses 3 to 8 weeks apart, and the third dose at least 8 weeks after the second.
As with older age groups, an 8-week interval between first and second dose may be optimal for children who are not immunocompromised as the longer interval may improve vaccine effectiveness and reduce the small risk of myocarditis and/or pericarditis associated with mRNA COVID-19 vaccines. Children who are moderately to severely immunocompromised should receive 3 primary series doses of either Moderna or Pfizer COVID-19 vaccines. See CDC People who are immunocompromised for details.
Moderna COVID-19 vaccine for children 6-17 years of age
The Moderna COVID-19 vaccine is now recommended for children ages 6 through 17 years. Previously only the Pfizer COVID-19 vaccine was recommended for children ages 17 and under.
The Moderna COVID-19 vaccine is administered as 2 doses, 4 to 8 weeks apart.
• Children 6-11 years: 50 mcg per dose.
• Adolescents 12-17 years: 100 mcg per dose (same dose as for adults).
Note: Supplies of the Moderna vaccine for 6-11 years are expected in Los Angeles County by July 7.
CDC Recommends Moderna COVID-19 Vaccine for Children and Adolescents
On June 24, 2022, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation that Moderna’s COVID-19 vaccine be used as an option for children ages 6 through 17 years, in addition to its already recommended use in children 6 months through 5 years and adults 18 years and older. This recommendation reinforces the use of Moderna’s COVID-19 vaccine as an important tool in the pandemic and provides another vaccine option for children and adolescents. The ACIP recommendation comes after a thorough review of the scientific evidence demonstrating safety and efficacy, and supports the use of the vaccine among those 6 through 17 years of age.
Expanded COVID-19 Vaccine Eligibility for Young Children
On June 18, 2022, CDC Director Rochelle P. Walensky, M.D., M.P.H., endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation that all children 6 months through 5 years of age should receive a COVID-19 vaccine. This expands eligibility for vaccination to nearly 20 million additional children and means that all Americans ages 6 months and older are now eligible for vaccination.
Parents and caregivers can now get their children 6 months through 5 years of age vaccinated with the Pfizer-BioNTech or Moderna vaccines to better protect them from COVID-19. All children, including children who have already had COVID-19, should get vaccinated.
For more information on the CDC’s COVID-19 vaccine recommendations for children and teens, click here.
CDC Strengthens Recomendations and Expands Eligibility for COVID-19 Booster Shots
CDC has expanded eligibility of COVID-19 vaccine booster doses to everyone 5 years of age and older, recommending that children ages 5 through 11 years should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination series. CDC has also strengthened its recommendation that those 12 and older who are immunocompromised and those 50 and older should receive a second booster dose at least 4 months after their first. Learn more here.
CDC Recommends Preference for mRNA Vaccines over Johnson & Johnson Vaccine
CDC’s new recommendation: mRNA COVID-19 vaccines (Pfizer and Moderna) are preferred over the Johnson & Johnson (Janssen) COVID-19 vaccine for the prevention of COVID-19 for all individuals 18 years of age and older. The Western States Scientific Safety Review Workgroup concurs with the decision given their greater effectiveness and stronger safety profile.
Given the current state of the pandemic both in the United States and around the world, the CDC’s ACIP reaffirmed that receiving any vaccine is better than being unvaccinated. In Los Angeles County, the supply of mRNA vaccines is abundant. When it is time to get a booster dose, individuals previously vaccinated with the Johnson & Johnson vaccine should consider boosters with Pfizer or Moderna.
The CDC's recommendation is based on new data on rare deaths from thrombosis with thrombocytopenia syndrome (TTS) following Johnson & Johnson (Janssen) COVID-19 vaccination.
- TTS rate is 1 case per 100,000 among females 30-40.
- 1 of 7 TTS cases has been fatal.
- FDA continues to find that the known and potential benefits of the Johnson & Johnson COVID-19 vaccine outweigh its known and potential risks.
View the FDA statement, including the updated factsheet here.
BCHD COVID-19 Testing & Vaccination Site Successes
Frequently Asked Questions
CDC recommends everyone ages 6 months and older get vaccinated against COVID-19. Everyone 5 years and older should also get a COVID-19 booster, if eligible.
The Advisory Committee on Immunization Practices (ACIP) is an independent panel of medical and public health experts brought together by the Centers for Disease Control and Prevention (CDC) to make recommendations about vaccine policies. The ACIP recommends to the CDC which people should be in each phase. While states often follow the ACIP recommendations, final decisions about when different groups will get the vaccine are made by each state. In California, those decisions are being made by the California Department of Public Health (CDPH). The Los Angeles County Department of Public Health refines the state’s plan and decides exactly how each phase of vaccine distribution will be carried out: where vaccines will be given, who will be giving the vaccines, and how the county will make sure everyone has a chance to get a vaccine when it is offered to people in their phase.
The Los Angeles County Department of Public Health has the following goals and principles to guide decisions about the order in which people are vaccinated.
- Reduce deaths and cases of serious disease
- Keep key healthcare services and the larger community operating
- Limit the extra strain that COVID-19 is having on people with chronic health conditions and people experiencing extreme hardship
- Do as much good and as little harm as possible. For example, make sure we use the vaccine that comes to Los Angeles County as efficiently as possible AND make sure people don’t have to go to crowded places where they could catch COVID-19 to get the vaccine.
- Reduce health inequities. This means that the needs of people who experience worse health due to poor living or working conditions are recognized in planning the phases for distribution.
- Promote justice. This means, for example, making sure richer people can’t buy their way to a place at the head of the line.
- Promote transparency. In other words, make sure the public has information on every step in the process and knows where they can get more information if they need it.
In addition, there are other things to consider, like how to offer the vaccine in a way that reaches as many of the people in each phase as possible. This is complicated, especially since we don’t want people to gather in big crowds where they can’t be six feet apart when they get vaccinated.
What COVID-19 vaccines are available?
- Pfizer-BioNTech / Comirnaty
- Moderna / Spikevax
- Janssen (Johnson & Johnson)
View the COVID-19 Vaccinations in LA County dashboard here. This does not include allocations for the Cities of Long Beach and Pasadena, which have their own independent health departments and are receiving their own allocations.
The FDA is globally respected for its scientific standards of vaccine safety, effectiveness and quality. The agency provides scientific and regulatory advice to vaccine developers and undertakes a rigorous evaluation of the scientific information through all phases of clinical trials, which continues after a vaccine has been approved or authorized for emergency use. Efforts to speed vaccine development have not sacrificed scientific standards, integrity of the vaccine review process or safety. Here is the path a COVID-19 vaccine must take to receive EUA.
Following each FDA hearing, the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) meet to vote on whether to recommend the vaccines and develop guidelines for prioritization. California has also launched an independent Safety Review Work Group with the states of Washington, Oregon and Nevada that also review and approve the safety and efficacy data before the vaccine can be distributed.
If you have had a severe allergic reaction—also known as anaphylaxis—to any ingredient in the Pfizer-BioNTech vaccine, the Moderna vaccine or the Janssen (Johnson & Johnson) vaccine, you should not get vaccinated. If you have had a severe allergic reaction to other vaccines or injectable therapies, ask your doctor if you should get one of the vaccines. Your doctor will help you decide if it is safe for you to get one of the COVID-19 vaccines. Source: CDC
- Pfizer-BioNTech: The most commonly reported side effects, which typically lasted several days, were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain and fever. More people experienced these side effects after the second dose than after the first dose; you can expect that there may be some side effects after either dose, but even more so after the second dose. Source: FDA
- Moderna: The most commonly reported side effects, which typically lasted several days, were pain at the injection site, tiredness, headache, muscle pain, chills, joint pain, swollen lymph nodes in the same arm as the injection, nausea and vomiting, and fever. More people experienced these side effects after the second dose than after the first dose; you can expect that there may be some side effects after either dose, but even more so after the second dose. Source: FDA
- Janssen (Johnson & Johnson): The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects occurred within 1-2 days following vaccination and were mild to moderate in severity and lasted 1-2 days. Source: FDA
- Experiencing side effects is a normal sign that your body is building protection. Source: CDC
- You may get side effects in the first 2 days after getting the vaccine. Side effects are more common in younger people. They usually do not last long, and you should feel better within a day or two. Source: Los Angeles County Department of Public Health
The vaccine will not alter your genetic information, or DNA. Just as its name says, mRNA works like a messenger; it tells your body to make a protein that kicks your immune system into action. mRNA never enters the nucleus of the cell, which is where our DNA is kept. The cell breaks down and gets rid of the mRNA soon after it is finished using the instructions. Source: Los Angeles County Department of Public Health, CDC
Mounting data shows that COVID-19 infection increases the risk of severe illness and pregnancy complications. Studies have also affirmed the vaccines’ safety in all stages of pregnancy. In light of these findings and the increase in cases across the country, the CDC strengthened its recommendation for COVID-19 vaccination for all women who are pregnant, breastfeeding, trying to get pregnant now, or might become pregnant in the future. The Los Angeles County Department of Public Health also encourages pregnant women and women who are breastfeeding to get vaccinated. Get the facts here.
Serious adverse events after COVID-19 vaccination are rare but may occur. Reports of adverse events to the Vaccine Adverse Event Reporting System (VAERS) following vaccination, including deaths, do not necessarily mean that a vaccine caused a health problem.
CDC is monitoring the following rare, serious adverse events of interest:
- Thrombosis with thrombocytopenia syndrome (TTS)
- Guillain-Barré Syndrome
- Myocarditis and pericarditis: Both myocarditis and pericarditis have the following symptoms: chest pain, shortness of breath and feelings of having a fast-beating, fluttering or pounding heart.
- Reports of death: More than 442 million doses of COVID-19 vaccines were administered in the United States from December 14, 2020, through November 15, 2021. During this time, VAERS received 9,810 reports of death (0.0022%) among people who received a COVID-19 vaccine.
- The clinical trial for the Pfizer-BioNTech COVID-19 vaccine demonstrated a very high efficacy of 95%. Efficacy was similar across age, sex, racial and ethnic groups, including those with one or more of the following underlying health conditions: obesity, diabetes, hypertension and chronic cardiopulmonary disease. Source: CDC
- The Moderna COVID-19 vaccine also has a very high efficacy of 94.1%. Efficacy was high among people of diverse age, sex, race, and ethnicity categories and among persons with underlying medical conditions. Source: CDC
- The Janssen (Johnson & Johnson) vaccine was 66.3% effective in clinical trials at preventing COVID-19 illness in people who had no evidence of prior infection 2 weeks after receiving the vaccine. People had the most protection 2 weeks after getting vaccinated. The vaccine also had high efficacy at preventing hospitalization and death in people who did get sick. No one who got COVID-19 at least 4 weeks after receiving the vaccine had to be hospitalized. Early evidence suggests that the Janssen (Johnson & Johnson) vaccine might provide protection against asymptomatic infection, which is when a person is infected by the virus that causes COVID-19 but does not get sick. Source: CDC
- According to the FDA, it is not possible to make comparisons about the effectiveness among the three COVID-19 vaccines. The only way to accurately compare the effectiveness of medical products, such as vaccines or drugs, is by direct comparison in head-to-head clinical trials, which did not occur for these vaccines. Furthermore, the clinical trials for these vaccines occurred in different geographic regions and at different points in time with varying incidence of COVID-19. All of the COVID-19 vaccines that the FDA has authorized for emergency use are at least 50% more effective than placebo in preventing COVID-19, consistent with FDA recommendations provided in the October 2020 guidance document, Emergency Use Authorization for Vaccines to Prevent COVID-19. A vaccine with at least 50% efficacy would have a significant impact on disease, both at the individual and societal level.
- mRNA COVID-19 vaccines are highly effective in preventing infections in real-world conditions: In a study of about 4,000 healthcare personnel, police, firefighters and other essential workers, the CDC found that the vaccines reduced the risk of infection, both asymptomatic and symptomatic infection by 80% after one dose, and that protection increased to 90% following the second dose. Different from the clinical trials, which are tightly controlled, and showed that the vaccines are highly effective preventing hospitalizations and deaths, this study shows just how effective the vaccines are in preventing infections in real-life conditions. The findings of this study are significant and provide evidence that the vaccines can both reduce transmission and save lives. Read the CDC’s report here.
According to the FDA, it is not possible to make comparisons about the effectiveness among the three COVID-19 vaccines. The only way to accurately compare the effectiveness of medical products, such as vaccines or drugs, is by direct comparison in head-to-head clinical trials, which did not occur for these vaccines. Furthermore, the clinical trials for these vaccines occurred in different geographic regions and at different points in time with varying incidence of COVID-19. All of the COVID-19 vaccines that the FDA has authorized for emergency use are at least 50% more effective than placebo in preventing COVID-19, consistent with FDA recommendations provided in the October 2020 guidance document, Emergency Use Authorization for Vaccines to Prevent COVID-19. A vaccine with at least 50% efficacy would have a significant impact on disease, both at the individual and societal level.
- Herd immunity means that enough people in a community are protected from getting a disease because they’ve already had the disease or because they’ve been vaccinated. Herd immunity makes it hard for the disease to spread from person to person, and it even protects those who cannot be vaccinated, like newborns or people who are allergic to the vaccine. The percentage of people who need to have protection to achieve herd immunity varies by disease. Experts do not yet know what percentage of people would need to get vaccinated to achieve herd immunity to COVID-19. CDC and other experts are studying herd immunity and will provide more information as it is available. Source: CDC
- Although the percentage of the population Los Angeles County needs to vaccinate to achieve community immunity (herd immunity) is unknown, the County Department of Public Health estimates it’s probably around 80%. As of May 10, 2021, 400,000 shots each week are getting into the arms of County residents, and there are over 2 million more first doses to go before 80% of all County residents 16 and older have received at least one shot. At this rate, the County Department of Public Health expects the County will reach this level of community immunity in mid- to late July and that assumes the County continues to at least have 400,000 people vaccinated each week. That would include both first doses that people need as well as their second doses. Source: Los Angeles County Department of Public Health
The Pfizer-BioNTech and Moderna vaccines are mRNA vaccines. mRNA vaccines are a new type of vaccine to protect against infectious diseases, but they are not unknown. Researchers have been studying and working with mRNA vaccines for decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials. This means the process can be standardized and scaled up, making vaccine development faster than traditional methods of making vaccines. As soon as the necessary information about the virus that causes COVID-19 was available, scientists began designing the mRNA instructions for cells to build the unique spike protein into an mRNA vaccine. mRNA vaccines teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies. Source: CDC
Yes, both the FDA and CDC confirm that the COVID-19 vaccines are effective against variants.
- While the FDA continues to develop an understanding of and address any impact of variants on FDA-regulated products, at this time, available information suggests that the authorized vaccines remain effective in protecting the American public against currently circulating strains of COVID-19. Source: FDA
- Studies suggest that antibodies generated through vaccination with currently authorized vaccines recognize these variants. This is being closely investigated and more studies are underway. Source: CDC
- Recent research findings provide added evidence that the currently available vaccines appear to be highly effective against the variants of concern that are circulating now. A new study by the CDC showed that over the last few months, during a period when the current viral variants have been circulating widely, vaccines reduced the risk of getting sick with COVID-19 by 94% among fully vaccinated healthcare workers.
COVID-19 vaccination will help keep you from getting COVID-19
- All COVID-19 vaccines currently available in the United States have been shown to be highly effective at preventing COVID-19.
- Based on what we know about vaccines for other diseases and early data from clinical trials, experts believe that getting a COVID-19 vaccine may also help keep you from getting seriously ill even if you do get COVID-19.
- Getting vaccinated yourself may also protect people around you, particularly people at increased risk for severe illness from COVID-19.
- Experts continue to conduct more studies about the effect of COVID-19 vaccination on severity of illness from COVID-19, as well as its ability to keep people from spreading the virus that causes COVID-19.
COVID-19 vaccination is a safer way to help build protection
- COVID-19 can have serious, life-threatening complications, and there is no way to know how COVID-19 will affect you. And if you get sick, you could spread the disease to friends, family, and others around you.
- Clinical trials of all vaccines must first show they are safe and effective before any vaccine can be authorized or approved for use, including COVID-19 vaccines. The known and potential benefits of a COVID-19 vaccine must outweigh the known and potential risks of the vaccine for use under what is known as an Emergency Use Authorization (EUA). Watch a video on what an EUA is.
- Getting COVID-19 may offer some natural protection, known as immunity. Current evidence suggests that reinfection with the virus that causes COVID-19 is uncommon in the 90 days after initial infection. However, experts don’t know for sure how long this protection lasts, and the risk of severe illness and death from COVID-19 far outweighs any benefits of natural immunity. COVID-19 vaccination will help protect you by creating an antibody (immune system) response without having to experience sickness.
- Both natural immunity and immunity produced by a vaccine are important parts of COVID-19 disease that experts are trying to learn more about, and CDC will keep the public informed as new evidence becomes available.
COVID-19 vaccination will be an important tool to help stop the pandemic
- Wearing masks and physical distancing help reduce your chance of being exposed to the virus or spreading it to others, but these measures are not enough. Vaccines will work with your immune system so it will be ready to fight the virus if you are exposed.
- The combination of getting vaccinated and following CDC’s recommendations to protect yourself and others will offer the best protection from COVID-19.
- Stopping a pandemic requires using all the tools we have available. As experts learn more about how COVID-19 vaccination may help reduce spread of the disease in communities, CDC will continue to update the recommendations to protect communities using the latest science.
- Both the Pfizer-BioNTech and Moderna vaccines require two doses. The Pfizer-BioNTech doses are given three weeks (21 days) apart and the Moderna four weeks (28 days) apart. You must receive the same vaccine for both doses. Your second dose should be administered as close to the recommended 21 days or 28 days interval as possible. However, if it is not feasible to adhere to the recommended interval, the second dose of Pfizer-BioNTech and Moderna COVID-19 vaccines may be scheduled for administration up to 6 weeks (42 days) after the first dose. Second doses administered within a grace period of 4 days earlier than the recommended date for the second dose are also considered valid. Source: CDC
- The Janssen (Johnson & Johnson) vaccine requires a single dose.
- The Novavax vaccine requires two doses in the primary series, given 3–8 weeks apart. People who are moderately or severely immunocompromised should also receive two doses, given three weeks apart (a 3rd primary dose is not currently authorized).
No. Your doctor or pharmacy may charge a fee for giving the vaccine, but it will be covered by public and private insurance companies. People without health insurance can get COVID-19 vaccines at no cost. There are no out-of-pocket payments. Source: Los Angeles County Department of Public Health
No. COVID-19 vaccine is being given to Los Angeles County residents at no cost regardless of immigration status. You should not be asked about your immigration status when you get vaccinated. Your medical information is private. Your doctor is not allowed to share it with immigration officials. Source: Los Angeles County Department of Public Health
More than 700 sites in Los Angeles County are administering the vaccines, including federally qualified health clinics, pharmacies, hospitals, and large capacity vaccination sites. For the full list of available vaccination sites, visit the County’s website here.
South Bay Pharmacy (520 N. Prospect Ave, Suite 110, Redondo Beach)
- Vaccines available: Pfizer, Moderna and Johnson & Johnson (subject to availability)
- For minors age 12-17: The Moderna and Johnson & Johnson vaccines are NOT authorized for this age group
- Monday – Friday, 9 a.m. – 1 p.m. and 2 – 5 p.m.
- Saturdays, 9 a.m. – 12 p.m.
- Walk-ins only
Yes, you should be vaccinated regardless of whether you already had COVID-19. That’s because experts do not yet know how long you are protected from getting sick again after recovering from COVID-19. Even if you have already recovered from COVID-19, it is possible—although rare—that you could be infected with the virus that causes COVID-19 again. Learn more about why getting vaccinated is a safer way to build protection than getting infected. If you were treated for COVID-19 with monoclonal antibodies or convalescent plasma, you should wait 90 days before getting a COVID-19 vaccine. Talk to your doctor if you are unsure what treatments you received or if you have more questions about getting a COVID-19 vaccine. Source: CDC
No. People with COVID-19 who have symptoms should wait to be vaccinated until they have recovered from their illness and have met the criteria for discontinuing isolation; those without symptoms should also wait until they meet the criteria before getting vaccinated. This guidance also applies to people who get COVID-19 before getting their second dose of vaccine.
Getting the vaccine is voluntary. Vaccines are an important public health measure to protect the health of not only yourself, but of your community. Healthcare providers and public health officials are trying to provide people with good information on the safety and effectiveness of these vaccines so that they can make an informed decision when it is their turn to be offered the vaccine. The Beach Cities Health District Medical Advisory Committee strongly recommends residents to get a COVID-19 vaccine that has been authorized by the FDA when it becomes available to them.
If you have pain or discomfort, talk to your doctor about taking over-the-counter medicine, such as ibuprofen, aspirin, antihistamines, or acetaminophen, for any pain and discomfort you may experience after getting vaccinated. You can take these medications to relieve post-vaccination side effects if you have no other medical reasons that prevent you from taking these medications normally. It is not recommended you take these medicines before vaccination for the purpose of trying to prevent side effects, because it is not known how these medications may impact how well the vaccine works.
To reduce pain and discomfort where you got the shot:
- Apply a clean, cool, wet washcloth over the area
- Use or exercise your arm
To reduce discomfort from fever:
- Drink plenty of fluids
- Dress lightly
In most cases, discomfort from fever or pain is normal. Contact your doctor or healthcare provider:
- If the redness or tenderness where you got the shot increases after 24 hours
- If your side effects are worrying you or do not seem to be going away after a few days
If you get a COVID-19 vaccine and you think you might be having a severe allergic reaction after leaving the vaccination site, seek immediate medical care by calling 911.
You are considered fully vaccinated when:
- Two weeks or more have passed since you received your second dose in a 2-dose vaccine series (Pfizer-BioNTech or Moderna); or
- Two weeks or more have passed since you received your dose of a single-dose vaccine (Johnson& Johnson/Janssen)
- It is possible to catch the disease in the first few days after your vaccination before the vaccine has a chance to work. For the Pfizer-BioNTech and Moderna vaccines, the vaccine needs 7 days before it starts to work for most people and the second dose is required before a person is fully protected from getting sick from the virus. For the Janssen (Johnson & Johnson) vaccine, which requires just one dose, people had the most protection 2 weeks after getting vaccinated in the clinical trials. Source: Los Angeles County Department of Public Health, CDC
- The CDC recently confirmed fewer than 0.007% of the nearly 90 million Americans with full protection against the virus have been infected with COVID-19; the vaccines are working as intended. Source: Los Angeles County Department of Public Health
There are several types of vaccination record:
- CDC COVID-19 vaccination record card (white paper card)
- California Department of Public Health (CDPH) COVID-19 vaccination digital record
- Other COVID-19 digital vaccination record
- California Immunization Registry (CAIR) vaccination record
- Documentation of vaccination from a healthcare provider
- Documentation of vaccination from an entity that provides COVID-19 vaccine
- World Health Organization (WHO) Vaccine Record Card (the Yellow Card)
Learn more from the Los Angeles County Department of Public Health here.
Minors age 12-17 can only receive the Pfizer vaccine. They cannot receive the Moderna or Johnson & Johnson vaccine because these vaccines are only authorized by the FDA for individuals age 18 and over. Source: Los Angeles County Department of Public Health
Teens 16 to 17 years of age were included in the efficacy analysis and one confirmed COVID-19 case was reported in this age group. The FDA has determined that it is biologically reasonable to extrapolate that safety and effectiveness in teens 16-17 years old would be similar to safety and effectiveness in younger adults. Source: FDA
Even though it is rare for children to get seriously ill from COVID-19, children who are 16 years and older have needed hospital care for COVID-19. This is especially true for teens with underlying health conditions such as weakened immune systems, obesity or chronic lung conditions. Having the vaccine may also give parents and teens alike peace of mind to return to more typical activities like in-person instruction and participating in sports, which is great for mental health. Source: Children’s Hospital Orange County
The information below applies to minors being vaccinated at a site run by the Los Angeles County Department of Public Health:
- For all minors age 12-17: a consent form signed by a parent or legal guardian is required for both visits.
- 16 and 17-year-olds should be accompanied by their parent or legal guardian if possible.
- 12-15 year-olds must be accompanied by their parent, legal guardian or a responsible adult. If the child is accompanied by a responsible adult, the consent form must name the responsible person and be signed by the parent or legal guardian. The responsible person must bring their photo ID.
- Note: If the minor is being vaccinated at school, consent is required; however, the school’s guidance should be followed on whether a parent/legal guardian or named adult needs to be present.
- Public Health consent form: English | Español
Consent forms are available at the vaccination site, or can be printed for free in LA County libraries.
Yes, all students over age 2 are required to wear face masks at all times while on school property except while eating, drinking or carrying out other activities that preclude use of face masks. Alternative protective strategies may be adopted to accommodate students who are on Individualized Education or 504 Plans and who cannot use or tolerate a face mask. Students who cannot wear a mask should not be placed with a cohort or group of students in the classroom. They may be able to tolerate a face shield with drape at the bottom which does not provide the same extent of source control or personal protection as use of a properly fitted, multi-layered face mask, therefore a student who cannot wear a mask can receive necessary services in a one-to-one setting with staff wearing appropriate PPE. They may also need to be accommodated via distance learning. Source: Los Angeles County Department of Public Health
If they have a fever, the teen should stay home. Beyond that, so long as they are feeling well, there is no need to limit activities. Source: Children’s Hospital Orange County
In the interest of maintaining the health and safety of students, employees, guests and all members of campus communities, the California State University (CSU) joined the University of California (UC) in announcing that the universities intend to require faculty, staff and students who are accessing campus facilities at any university location to be immunized against SARS-CoV-2, the virus that causes COVID-19. This requirement will be conditioned upon full approval of one or more vaccines by the U.S. Food and Drug Administration (FDA), as well as adequate availability of the fully approved vaccines. This requirement will become effective at the beginning of the fall 2021 term, or upon full FDA approval of the vaccine, whichever occurs later. Source: CSU
The Pfizer COVID-19 vaccine for 5-11 year-olds will be a new product with new packaging, new product configuration (10-dose vial), different dosage and injection volume, and have a new National Drug Code (NDC). Current product for adults and adolescents cannot be used in children under 12 years of age.
Immune responses of children 5-11 years old were comparable to those of individuals 16-25 years old. In addition, the vaccine was found to be 90.7% effective in preventing COVID-19 in children 5-11. Source: FDA
The Pfizer-BioNTech COVID-19 Vaccine for children 5-11 years old is administered as a two-dose primary series, 3 weeks apart, but is a lower dose (10 micrograms) than that used for individuals 12 years and older (30 micrograms). Source: FDA
If a child turns from 11 to 12 years of age in between their first and second dose, the second dose should be the Pfizer-BioNTech vaccine for people 12 years and older. However, if the child receives the Pfizer-BioNTech COVID-19 vaccine for children ages 5 through 11 for their second dose, they do not need to repeat the dose. Source: CDC
Commonly reported side effects in the clinical trial included injection site pain (sore arm), redness and swelling, fatigue, headache, muscle and/or joint pain, chills, fever, swollen lymph nodes, nausea and decreased appetite. More children reported side effects after the second dose than after the first dose. Side effects were generally mild to moderate in severity and occurred within two days after vaccination, and most went away within one to two days. Source: FDA
Ask your child’s healthcare provider for advice on using a non-aspirin pain reliever and other steps you can take at home after your child gets vaccinated. In general, aspirin is not recommended for use in children and adolescents less than 18 years of age. Placing a cool, damp cloth on the injection site can help with discomfort. Also, it is not recommended you give pain relievers before vaccination to try to prevent side effects. Source: CDC